Extreme growth factor signalling can promote oestrogen receptor-α loss: therapeutic implications in breast cancer

Ítems similars

• Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells
  per: Borley, Annabel C, et al.
  Publicat: (2008)
• Anti-oestrogen therapy switches off tumour suppressors and proapoptotic genes in breast cancer and reveals a new therapeutic opportunity
  per: Stone, A, et al.
  Publicat: (2008)
• Loss of oestrogen receptor alpha in long-term antioestrogen-resistant cells: reversal by a c-src inhibitor
  per: Bensmail, A, et al.
  Publicat: (2008)
• Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization
  per: Gee, Julia MW, et al.
  Publicat: (2003)
• Complementary yet distinct roles for oestrogen receptor-α and oestrogen receptor-β in mouse mammary epithelial proliferation
  per: Clarke, Robert B
  Publicat: (2004)